BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37047126)

  • 1. Epstein-Barr Virus Reactivation as a New Predictor of Achieving Remission or Lupus Low Disease Activity State in Patients with Systemic Lupus Erythematosus with Cutaneous Involvement.
    Miskovic R; Cirkovic A; Miljanovic D; Jeremic I; Grk M; Basaric M; Lazarevic I; Stojanovic M; Plavsic A; Raskovic S; Banko A
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INFECTIOUSNESS OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS.
    Guta S; Abrahamovych O; Abrahamovych U; Tsyhanyk L; Farmaha M
    Georgian Med News; 2023 May; (338):121-125. PubMed ID: 37419485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus infection as potential indicator of the occurrence and clinical presentation of systemic lupus erythematosus.
    Banko A; Cirkovic A; Miskovic R; Jeremic I; Grk M; Basaric M; Lazarevic I; Raskovic S; Despotovic A; Miljanovic D
    Front Immunol; 2023; 14():1307589. PubMed ID: 38146370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
    Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
    Chougule D; Nadkar M; Rajadhyaksha A; Pandit-Shende P; Surve P; Dawkar N; Khadilkar P; Patwardhan M; Kaveri S; Ghosh K; Pradhan V
    J Med Virol; 2018 Mar; 90(3):559-563. PubMed ID: 28734074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
    Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
    J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity.
    Aygun D; Kuskucu MA; Sahin S; Adrovic A; Barut K; Yıldız M; Sharifova S; Midilli K; Cokugras H; Camcıoglu Y; Kasapcopur O
    Lupus; 2020 Sep; 29(10):1263-1269. PubMed ID: 32646294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective cohort study of Epstein-Barr virus infection status and systemic lupus erythematosus.
    Chen M; Tu J; Huang M; Cheng Y; Sun L
    Clin Rheumatol; 2024 May; 43(5):1521-1530. PubMed ID: 38509241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus reactivation and disease flare of systemic lupus erythematosus.
    Chen CJ
    Taiwan J Obstet Gynecol; 2024 Mar; 63(2):161-164. PubMed ID: 38485308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus early antigen diffuse (EBV-EA/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients.
    Draborg AH; Jørgensen JM; Müller H; Nielsen CT; Jacobsen S; Iversen LV; Theander E; Nielsen LP; Houen G; Duus K
    Scand J Rheumatol; 2012 Aug; 41(4):280-9. PubMed ID: 22646970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-Time PCR of cytomegalovirus and Epstein-Barr virus in adult Egyptian patients with systemic lupus erythematosus.
    Mohamed AE; Hasen AM; Mohammed GF; Elmaraghy NN
    Int J Rheum Dis; 2015 May; 18(4):452-8. PubMed ID: 24341363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of the Epstein-Barr Virus in Autoimmune Inflammatory Rheumatic Diseases in Northern Brazil.
    França SAS; Viana JBGO; Góes HCA; Fonseca RRS; Laurentino RV; Costa IB; Oliveira-Filho AB; Machado LFA
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Human Leucocyte Antigen Class II, with viral load and immune response to Epstein-Barr virus in adult and pediatric Systemic lupus erythematosus patients.
    Das P; Minz RW; Saikia B; Sharma A; Anand S; Singh H; Singh S
    Lupus; 2022 Aug; 31(9):1054-1066. PubMed ID: 35607991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals.
    Jog NR; Young KA; Munroe ME; Harmon MT; Guthridge JM; Kelly JA; Kamen DL; Gilkeson GS; Weisman MH; Karp DR; Gaffney PM; Harley JB; Wallace DJ; Norris JM; James JA
    Ann Rheum Dis; 2019 Sep; 78(9):1235-1241. PubMed ID: 31217170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients.
    Rasmussen NS; Draborg AH; Nielsen CT; Jacobsen S; Houen G
    Scand J Rheumatol; 2015; 44(2):143-9. PubMed ID: 25562120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies.
    Laurynenka V; Ding L; Kaufman KM; James JA; Harley JB
    Front Immunol; 2022; 13():830993. PubMed ID: 35251022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan.
    Lu JJ; Chen DY; Hsieh CW; Lan JL; Lin FJ; Lin SH
    Lupus; 2007; 16(3):168-75. PubMed ID: 17432101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study.
    Esen BA; Yılmaz G; Uzun S; Ozdamar M; Aksözek A; Kamalı S; Türkoğlu S; Gül A; Ocal L; Aral O; Inanç M
    Rheumatol Int; 2012 Jan; 32(1):79-83. PubMed ID: 20661740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein‒Barr virus and human herpesvirus 6 infection in patients with systemic lupus erythematosus.
    Chen X; Li H; Wu C; Zhang Y
    Virol J; 2023 Feb; 20(1):29. PubMed ID: 36782252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease.
    Zandman-Goddard G; Berkun Y; Barzilai O; Boaz M; Blank M; Ram M; Sherer Y; Anaya JM; Shoenfeld Y
    Ann N Y Acad Sci; 2009 Sep; 1173():658-63. PubMed ID: 19758212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.